CR GROUP L.P. sold 13.13M shares of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $2.27M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−2.39M
Price / share
$0.19
Trade value
$458.30K
% of position
Common Stock
Shares
−1.49M
Price / share
$0.19
Trade value
$285.39K
% of position
Common Stock
Shares
−478.40K
Price / share
$0.19
Trade value
$91.66K
% of position
Common Stock
Shares
−1.62M
Price / share
$0.19
Trade value
$310.64K
% of position
Common Stock
Shares
−2.86M
Price / share
$0.16
Trade value
$450.29K
% of position
Common Stock
Shares
−1.78M
Price / share
$0.16
Trade value
$280.40K
% of position
Common Stock
Shares
−571.80K
Price / share
$0.16
Trade value
$90.06K
% of position
Common Stock
Shares
−1.94M
Price / share
$0.16
Trade value
$305.21K
% of position
Net shares
−13.13M
Net value
-$2.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/27/2023 | S · Sale | −2.39M | $0.19 | $458.30K | 45.6% | 5.25M | 2.86M |
| Common Stock Indirect | 9/27/2023 | S · Sale | −1.49M | $0.19 | $285.39K | 45.6% | 3.27M | 1.78M |
| Common Stock Indirect | 9/27/2023 | S · Sale | −478.40K | $0.19 | $91.66K | 45.6% | 1.05M | 571.80K |
| Common Stock Indirect | 9/27/2023 | S · Sale | −1.62M | $0.19 | $310.64K | 45.6% | 3.56M | 1.94M |
| Common Stock Indirect | 9/28/2023 | S · Sale | −2.86M | $0.16 | $450.29K | New position | 2.86M | 0.00 |
| Common Stock Indirect | 9/28/2023 | S · Sale | −1.78M | $0.16 | $280.40K | New position | 1.78M | 0.00 |
| Common Stock Indirect | 9/28/2023 | S · Sale | −571.80K | $0.16 | $90.06K | New position | 571.80K | 0.00 |
| Common Stock Indirect | 9/28/2023 | S · Sale | −1.94M | $0.16 | $305.21K | New position | 1.94M | 0.00 |
| Total | −13.13M | -$2.27M | ||||||